Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lala

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Molecular Endocrinology (Baltimore, Md.)|March 5, 2002
Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanismYu Li, Charles Bolten, B Ganesh Bhat, et al.
Substance Abuse|July 14, 2006
Creating change agents: a national substance abuse education projectMarianne T Marcus, Richard L Brown, S Lala A Straussner, et al.
Molecular Endocrinology (Baltimore, Md.)|March 12, 2005
The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanismsMonica L Hultman, Nataliia V Krasnoperova, Suzhen Li, et al.
Journal of Interprofessional Care|November 11, 2006
Interdisciplinary benefits in Project MAINSTREAM: a promising health professions educational model to address global substance abuseTheresa E Madden, Antonnette V Graham, S Lala A Straussner, et al.
Genes & Development|October 1, 1994
The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axisH A Ingraham, D S Lala, Y Ikeda, et al.
Nature|October 3, 1996
Activation of specific RXR heterodimers by an antagonist of RXR homodimersD S Lala, R Mukherjee, I G Schulman, et al.
Recent Progress in Hormone Research|May 23, 2002
Steroidogenic factor 1: an essential mediator of endocrine developmentKeith L Parker, Douglas A Rice, Deepak S Lala, et al.
Gut|October 23, 2003
Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitisY Ogura, S Lala, W Xin, et al.
European Journal of Pharmacology|December 3, 2014
Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetesBradford S Hamilton, Frank Himmelsbach, Herbert Nar, et al.
Bioorganic & Medicinal Chemistry|February 22, 2016
Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonistsStephen D Lotesta, Andrew P Marcus, Yajun Zheng, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Molecular Endocrinology (Baltimore, Md.)|March 5, 2002
Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanismYu Li, Charles Bolten, B Ganesh Bhat, et al.
Substance Abuse|July 14, 2006
Creating change agents: a national substance abuse education projectMarianne T Marcus, Richard L Brown, S Lala A Straussner, et al.
Molecular Endocrinology (Baltimore, Md.)|March 12, 2005
The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanismsMonica L Hultman, Nataliia V Krasnoperova, Suzhen Li, et al.
Journal of Interprofessional Care|November 11, 2006
Interdisciplinary benefits in Project MAINSTREAM: a promising health professions educational model to address global substance abuseTheresa E Madden, Antonnette V Graham, S Lala A Straussner, et al.
Genes & Development|October 1, 1994
The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axisH A Ingraham, D S Lala, Y Ikeda, et al.
Nature|October 3, 1996
Activation of specific RXR heterodimers by an antagonist of RXR homodimersD S Lala, R Mukherjee, I G Schulman, et al.
Recent Progress in Hormone Research|May 23, 2002
Steroidogenic factor 1: an essential mediator of endocrine developmentKeith L Parker, Douglas A Rice, Deepak S Lala, et al.
Gut|October 23, 2003
Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitisY Ogura, S Lala, W Xin, et al.
European Journal of Pharmacology|December 3, 2014
Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetesBradford S Hamilton, Frank Himmelsbach, Herbert Nar, et al.
Bioorganic & Medicinal Chemistry|February 22, 2016
Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonistsStephen D Lotesta, Andrew P Marcus, Yajun Zheng, et al.
Pageof 6